• Therapy areas
  • Products
  • Careers
  • About us
  • Patient help
  • Healthcare professionals
  • Media & Investors
  • Contact us

Ozempic® (semaglutide) injection

Ozempic® (semaglutide) tablets

Rybelsus® (semaglutide) tablets

Victoza® (liraglutide) injection

Awiqli® (insulin icodec-abae) injection

Fiasp® (insulin aspart) injection

Novolin® 70/30 (70% human insulin isophane suspension and 30% human insulin) injection

Novolin® N (isophane insulin human) suspension

Novolin® R (insulin human) injection

NovoLog® (insulin aspart) injection 100 U/mL

NovoLog® Mix 70/30 (insulin aspart protamine and insulin aspart) injectable suspension 100 U/mL

Tresiba® (insulin degludec) injection 100 U/mL, 200 U/mL

Xultophy® 100/3.6 (insulin degludec and liraglutide) injection

Zegalogue® (dasiglucagon) injection

Blood glucose monitoring

© 2026 Novo Nordisk All rights reserved. US26DI00021 August 2026

NOVO USA

800 Scudders Mill Road
Plainsboro, NJ 08536
Tel: 1-609-987-5800

 

Transparency in Employee Health Coverage:

Aetna
United Healthcare

Helpful links

  • Contact us
  • Copyright
  • Report a side effect or product complaint

Follow us

  • Instagram
  • Facebook
  • X (Twitter)
  • TikTok
  • LinkedIn

Other offices

Select location
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Privacy Policy
Consumer Health Data Privacy Notice
Cookie Notice
Cookie Settings
Your Privacy Choices